Anti-cytokine autoantibodies: Epiphenomenon or critical modulators of cytokine action

作者: Peter H. van der Meide , Huub Schellekens

DOI: 10.1007/BF02678216

关键词:

摘要: Low amounts of high-affinity autoantibodies to various cytokines have been detected in sera from healthy donors. Their levels, although highly variable, are increased the circulation patients subjected cytokine therapy or suffering a variety immunoinflammatory diseases. It has suggested that these play regulatory role intensity and duration an immune response. The antibodies may prevent binding its specific cell surface receptor thereby neutralizing biological activity vivo. They also act as carrier proteins preventing rapid elimination thus increase bioactivity. Additionally alternatively, modulate cytokine-induced intracellular signal transduction pathways trigger complement-mediated cytotoxicity towards cells carrying membrane-bound cytokines. exert their compliance with other factors control activity, including soluble receptors, decoy antagonists. Although not favored by many investigators, less sophisticated for naturally occurring anti-cytokine should be considered well. Recent evidence shown generated at high frequency part response foreign antigens. These produced B arising process somatic mutation. Thus result “leaky” triggered processes.

参考文章(93)
R A Figlin, J B deKernion, E Mukamel, A V Palleroni, L M Itri, G P Sarna, Recombinant interferon alfa-2a in metastatic renal cell carcinoma: assessment of antitumor activity and anti-interferon antibody formation. Journal of Clinical Oncology. ,vol. 6, pp. 1604- 1610 ,(1988) , 10.1200/JCO.1988.6.10.1604
J R Quesada, A Rios, D Swanson, P Trown, J U Gutterman, Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma. Journal of Clinical Oncology. ,vol. 3, pp. 1522- 1528 ,(1985) , 10.1200/JCO.1985.3.11.1522
T. O. Rosenbach, S. Moshonov, U. Zor, M. Yaron, Interferon triggers experimental synovitis and may potentiate auto-immune disease in humans Clinical Rheumatology. ,vol. 3, pp. 361- 364 ,(1984) , 10.1007/BF02032343
Guido Antonelli, Gianluigi Giannelli, M Currenti, E Simeoni, S Del Vecchio, Fabrizio Maggi, Mauro Pistello, L Roffi, G Pastore, Liliana Chemello, F Dianzani, None, Antibodies to interferon (IFN) in hepatitis C patients relapsing while continuing recombinant IFN-α2 therapy Clinical and Experimental Immunology. ,vol. 104, pp. 384- 387 ,(1996) , 10.1046/J.1365-2249.1996.43747.X
Nobuaki Sekido, Naofumi Mukaida, Akihisa Harada, Isao Nakanishi, Yoh Watanabe, Kouji Matsushima, Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8 Nature. ,vol. 365, pp. 654- 657 ,(1993) , 10.1038/365654A0
B Varet, K.E Mogensen, PH Daubas, I Gresser, D Sereni, PATIENT WITH CIRCULATING ANTIBODIES TO α-INTERFERON The Lancet. ,vol. 318, pp. 1227- 1228 ,(1981) , 10.1016/S0140-6736(81)91460-4
J.G. Gribben, S. Devereux, N.S.B. Thomas, M. Keim, H.M. Jones, A.H. Goldstone, D.C. Linch, Development of antibodies to unprotected glycosylation sites on recombinant human GM-CSF The Lancet. ,vol. 335, pp. 434- 437 ,(1990) , 10.1016/0140-6736(90)90665-R
C. ROSS, M. SVENSON, M.B. HANSEN, G.L. VEIJLSGAARD, K. BENDTZEN, Specific Autoantibodies Directed Against Interferon-α in Pharmaceutically Prepared Human Immunoglobulin Preparations Journal of interferon research. ,vol. 14, pp. 159- 160 ,(1994) , 10.1089/JIR.1994.14.159
Pascal Chazerain, Rheumatoid Arthritis-like Disease after Alpha-Interferon Therapy Annals of Internal Medicine. ,vol. 116, pp. 427- 427 ,(1992) , 10.7326/0003-4819-116-5-427_1